Effects of Periodic Transcranial Direct Current Stimulation in the Management of Individuals with Fibromyalgia Syndrome: Design of a Randomized Clinical Trial with 1 Year Follow-up

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR201908783085618

Enrollment

Registered

2019-08-13

Start date

2019-12-02

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases

Interventions

Long interval tDCS

periodic tDCS

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The inclusion criteria will be participants; 1) who fulfilled the American College of Rheumatology criteria for fibromyalgia (20), 2) adults aged from 19 to 44 years old and, 3) able to provide informed consent.

Exclusion criteria

Exclusion criteria: The exclusion criteria will be participants; 1) with psychiatric or behavioral conditions, 2) with severe cardio-respiratory problems and, 3) who have red flags (history of significant trauma, cancer, constitutional symptoms; fever, malaise, weight loss, recent infection, bladder and/or bowel dysfunction).

Design outcomes

Primary

Measure	Time frame
self report measures including pain, disability, sleep disturbance, mood disturbance, quality of life	—

Secondary

Measure	Time frame
objective measures including timed up and go test, lower back and harmstring flexibilities	—

Countries

Nigeria

Contacts

Public ContactSHEHU USMAN IBRAHIM

ORTHOPEDIC AND SPORTS PHYSIOTHERAPIST

umanik28@gmail.com+2347030433882

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026